DK3122378T3 - Mutante stafylokokantigener - Google Patents
Mutante stafylokokantigener Download PDFInfo
- Publication number
- DK3122378T3 DK3122378T3 DK15711523.9T DK15711523T DK3122378T3 DK 3122378 T3 DK3122378 T3 DK 3122378T3 DK 15711523 T DK15711523 T DK 15711523T DK 3122378 T3 DK3122378 T3 DK 3122378T3
- Authority
- DK
- Denmark
- Prior art keywords
- staphylococcal antigens
- mutant staphylococcal
- mutant
- antigens
- staphylococcal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14161861 | 2014-03-26 | ||
EP14192913 | 2014-11-12 | ||
PCT/EP2015/056175 WO2015144653A1 (en) | 2014-03-26 | 2015-03-24 | Mutant staphylococcal antigens |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3122378T3 true DK3122378T3 (da) | 2020-03-02 |
Family
ID=52706188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15711523.9T DK3122378T3 (da) | 2014-03-26 | 2015-03-24 | Mutante stafylokokantigener |
Country Status (24)
Country | Link |
---|---|
US (1) | US10328140B2 (da) |
EP (2) | EP3122378B1 (da) |
JP (2) | JP6894237B2 (da) |
KR (3) | KR102297357B1 (da) |
CN (2) | CN106103469B (da) |
AU (1) | AU2015238512B2 (da) |
BE (2) | BE1022857A1 (da) |
CA (1) | CA2942450A1 (da) |
CY (1) | CY1122537T1 (da) |
DK (1) | DK3122378T3 (da) |
EA (1) | EA037818B1 (da) |
ES (1) | ES2769647T3 (da) |
HR (1) | HRP20200217T1 (da) |
HU (1) | HUE047808T2 (da) |
IL (2) | IL247328B (da) |
LT (1) | LT3122378T (da) |
MX (1) | MX2016012538A (da) |
PL (1) | PL3122378T3 (da) |
PT (1) | PT3122378T (da) |
RS (1) | RS59971B1 (da) |
SG (1) | SG11201606887WA (da) |
SI (1) | SI3122378T1 (da) |
WO (2) | WO2015144655A1 (da) |
ZA (1) | ZA201605818B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014CN02152A (da) * | 2011-09-01 | 2015-09-04 | Novartis Ag | |
IL314130A (en) | 2016-05-16 | 2024-09-01 | Access To Advanced Health Inst | Formulation containing a TLR agonist and methods of use |
GB201802339D0 (en) * | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
CN109526985B (zh) * | 2018-11-19 | 2021-03-12 | 黑龙江省农垦科学院 | 土地类芽胞杆菌蛋白EsxA作为水稻稻瘟病生物防治剂的应用 |
EP3777884A1 (en) | 2019-08-15 | 2021-02-17 | GlaxoSmithKline Biologicals S.A. | Immunogenic composition |
AU2020358862A1 (en) | 2019-10-02 | 2022-04-14 | Janssen Vaccines & Prevention B.V. | Staphylococcus peptides and methods of use |
Family Cites Families (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
EP0114787B1 (de) | 1983-01-25 | 1991-09-25 | Ciba-Geigy Ag | Neue Peptidderivate |
IL73534A (en) | 1983-11-18 | 1990-12-23 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds |
US4680338A (en) | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US5238944A (en) | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
US4929624A (en) | 1989-03-23 | 1990-05-29 | Minnesota Mining And Manufacturing Company | Olefinic 1H-imidazo(4,5-c)quinolin-4-amines |
HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
US4988815A (en) | 1989-10-26 | 1991-01-29 | Riker Laboratories, Inc. | 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines |
DE69229114T2 (de) | 1991-03-01 | 1999-11-04 | Minnesota Mining And Mfg. Co., Saint Paul | 1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine |
US5389640A (en) | 1991-03-01 | 1995-02-14 | Minnesota Mining And Manufacturing Company | 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines |
US5268376A (en) | 1991-09-04 | 1993-12-07 | Minnesota Mining And Manufacturing Company | 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines |
US5266575A (en) | 1991-11-06 | 1993-11-30 | Minnesota Mining And Manufacturing Company | 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines |
IL105325A (en) | 1992-04-16 | 1996-11-14 | Minnesota Mining & Mfg | Immunogen/vaccine adjuvant composition |
US5395937A (en) | 1993-01-29 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Process for preparing quinoline amines |
SG48309A1 (en) | 1993-03-23 | 1998-04-17 | Smithkline Beecham Biolog | Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a |
JPH09500128A (ja) | 1993-07-15 | 1997-01-07 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | イミダゾ〔4,5−c〕ピリジン−4−アミン |
US5352784A (en) | 1993-07-15 | 1994-10-04 | Minnesota Mining And Manufacturing Company | Fused cycloalkylimidazopyridines |
AU5543294A (en) | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
GB9326174D0 (en) | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
US5482936A (en) | 1995-01-12 | 1996-01-09 | Minnesota Mining And Manufacturing Company | Imidazo[4,5-C]quinoline amines |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
AU753688B2 (en) | 1997-03-10 | 2002-10-24 | Ottawa Civic Loeb Research Institute | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
TR199902437T2 (xx) * | 1997-04-01 | 2000-01-21 | Corixa Corporation | Monofosforil lipid A'ya ait sulu im�nolojik adjuvant terkipleri. |
US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
US6562798B1 (en) | 1998-06-05 | 2003-05-13 | Dynavax Technologies Corp. | Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
US6110929A (en) | 1998-07-28 | 2000-08-29 | 3M Innovative Properties Company | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
GB9817052D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Biolog | Vaccine |
CA2773698C (en) | 1998-10-16 | 2015-05-19 | Glaxosmithkline Biologicals S.A. | Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
EP1123743A1 (en) | 1998-10-22 | 2001-08-16 | Yosuke Naito | Showerhead |
US20030130212A1 (en) | 1999-01-14 | 2003-07-10 | Rossignol Daniel P. | Administration of an anti-endotoxin drug by intravenous infusion |
US6551600B2 (en) | 1999-02-01 | 2003-04-22 | Eisai Co., Ltd. | Immunological adjuvant compounds compositions and methods of use thereof |
CA2361421A1 (en) | 1999-02-03 | 2000-08-10 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of manufacture and use |
US6331539B1 (en) | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
ES2298269T3 (es) | 2000-09-26 | 2008-05-16 | Idera Pharmaceuticals, Inc. | Modulacion de la actividad inmunoestimulante de analogos oligonucleotidicos inmunoestimulantes mediante cambios quimicos posicionales. |
US6664264B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
US6677347B2 (en) | 2000-12-08 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamido ether substituted imidazoquinolines |
US6660747B2 (en) | 2000-12-08 | 2003-12-09 | 3M Innovative Properties Company | Amido ether substituted imidazoquinolines |
US6677348B2 (en) | 2000-12-08 | 2004-01-13 | 3M Innovative Properties Company | Aryl ether substituted imidazoquinolines |
US6664265B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Amido ether substituted imidazoquinolines |
UA74852C2 (en) | 2000-12-08 | 2006-02-15 | 3M Innovative Properties Co | Urea-substituted imidazoquinoline ethers |
US6660735B2 (en) | 2000-12-08 | 2003-12-09 | 3M Innovative Properties Company | Urea substituted imidazoquinoline ethers |
US6664260B2 (en) | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Heterocyclic ether substituted imidazoquinolines |
US6667312B2 (en) | 2000-12-08 | 2003-12-23 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
WO2003035836A2 (en) | 2001-10-24 | 2003-05-01 | Hybridon Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
US6677349B1 (en) | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
WO2003101949A2 (en) | 2002-05-29 | 2003-12-11 | 3M Innovative Properties Company | Process for imidazo[4,5-c]pyridin-4-amines |
KR20090051129A (ko) | 2004-04-05 | 2009-05-20 | 화이자 프로덕츠 인코포레이티드 | 미세유체화된 수중유 유화액 및 백신 조성물 |
EP1802335A2 (en) * | 2004-10-21 | 2007-07-04 | Wyeth a Corporation of the State of Delaware | Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
US20060228369A1 (en) | 2005-04-11 | 2006-10-12 | Program For Appropriate Technology In Health | Stabilization and preservation of temperature-sensitive vaccines |
US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
TWI382019B (zh) | 2005-08-19 | 2013-01-11 | Array Biopharma Inc | 作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯 |
GB0526038D0 (en) | 2005-12-21 | 2006-02-01 | Glaxosmithkline Biolog Sa | Immunogenic composition |
FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
CN101466406B (zh) | 2006-06-12 | 2012-06-27 | 葛兰素史密斯克蓝生物品公司 | α-毒素在治疗和预防葡萄球菌感染上的用途 |
WO2008005555A1 (en) | 2006-07-07 | 2008-01-10 | Gilead Sciences, Inc. | Modulators of toll-like receptor 7 |
PT2086582E (pt) | 2006-10-12 | 2013-01-25 | Glaxosmithkline Biolog Sa | Vacina compreendendo uma emulsão adjuvante óleo em água |
US20090007256A1 (en) | 2007-06-28 | 2009-01-01 | Microsoft Corporation | Using a trusted entity to drive security decisions |
WO2009029831A1 (en) | 2007-08-31 | 2009-03-05 | University Of Chicago | Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
PE20091236A1 (es) | 2007-11-22 | 2009-09-16 | Astrazeneca Ab | Derivados de pirimidina como immunomoduladores de tlr7 |
WO2009111337A1 (en) | 2008-03-03 | 2009-09-11 | Irm Llc | Compounds and compositions as tlr activity modulators |
PT2276486E (pt) | 2008-03-24 | 2013-12-04 | 4Sc Discovery Gmbh | Novas imidazoquinolinas substituídas |
EP2313111B1 (en) | 2008-08-01 | 2013-09-04 | Ventirx Pharmaceuticals, Inc. | Toll-like receptor agonist formulations and their use |
EP2208787A1 (en) * | 2009-01-19 | 2010-07-21 | Université de Liège | A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
KR101773368B1 (ko) * | 2009-04-03 | 2017-08-31 | 유니버시티 오브 시카고 | 단백질 A(SpA) 변이체와 관련된 조성물 및 방법 |
SG175092A1 (en) * | 2009-04-14 | 2011-11-28 | Novartis Ag | Compositions for immunising against staphylococcus aerus |
CN102844047B (zh) | 2009-09-02 | 2017-04-05 | 诺华股份有限公司 | 含tlr活性调节剂的免疫原性组合物 |
JP2013523818A (ja) * | 2010-04-05 | 2013-06-17 | ザ・ユニバーシティー・オブ・シカゴ | 免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法 |
ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
JP5793194B2 (ja) * | 2010-09-09 | 2015-10-14 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | 感染防御ブドウ球菌抗原が関与する方法および組成物 |
IN2014CN02152A (da) * | 2011-09-01 | 2015-09-04 | Novartis Ag | |
JP2015500864A (ja) | 2011-12-23 | 2015-01-08 | ノバルティス アーゲー | 黄色ブドウ球菌(Staphylococcusaureus)に対して免疫するための安定な組成物 |
PL2822947T3 (pl) | 2012-03-07 | 2017-01-31 | Glaxosmithkline Biologicals Sa | Sole argininowe agonisty TLR7 |
AU2013229432A1 (en) | 2012-03-08 | 2014-10-16 | Novartis Ag | Adjuvanted formulations of booster vaccines |
JP2015528456A (ja) | 2012-08-31 | 2015-09-28 | ノバルティス アーゲー | Staphylococcusaureusに対する免疫化のための安定化されたタンパク質 |
WO2014033192A1 (en) | 2012-08-31 | 2014-03-06 | Novartis Ag | Stabilised proteins for immunising against staphylococcus aureus |
CN104684570A (zh) * | 2012-08-31 | 2015-06-03 | 诺华股份有限公司 | 用于免疫抵抗金黄色葡萄球菌的稳定化的蛋白质 |
CN110563818A (zh) | 2012-08-31 | 2019-12-13 | 诺华股份有限公司 | 用于针对金黄色葡萄球菌的免疫的稳定化的蛋白质 |
CN103694322B (zh) | 2013-12-09 | 2016-08-17 | 成都欧林生物科技股份有限公司 | 金黄色葡萄球菌SpA5突变体及其制备方法和应用 |
CN103645318B (zh) * | 2013-12-09 | 2016-11-02 | 成都欧林生物科技股份有限公司 | 金黄色葡萄球菌SpA5突变体抗原特异性IgG抗体检测方法和检测试剂盒 |
-
2015
- 2015-03-24 EA EA201691502A patent/EA037818B1/ru unknown
- 2015-03-24 CA CA2942450A patent/CA2942450A1/en active Pending
- 2015-03-24 ES ES15711523T patent/ES2769647T3/es active Active
- 2015-03-24 WO PCT/EP2015/056179 patent/WO2015144655A1/en active Application Filing
- 2015-03-24 CN CN201580014701.3A patent/CN106103469B/zh active Active
- 2015-03-24 KR KR1020197027986A patent/KR102297357B1/ko active IP Right Grant
- 2015-03-24 US US15/127,537 patent/US10328140B2/en active Active
- 2015-03-24 SI SI201531080T patent/SI3122378T1/sl unknown
- 2015-03-24 AU AU2015238512A patent/AU2015238512B2/en active Active
- 2015-03-24 WO PCT/EP2015/056175 patent/WO2015144653A1/en active Application Filing
- 2015-03-24 PT PT157115239T patent/PT3122378T/pt unknown
- 2015-03-24 HU HUE15711523A patent/HUE047808T2/hu unknown
- 2015-03-24 DK DK15711523.9T patent/DK3122378T3/da active
- 2015-03-24 EP EP15711523.9A patent/EP3122378B1/en active Active
- 2015-03-24 CN CN202011253615.7A patent/CN112521464A/zh active Pending
- 2015-03-24 PL PL15711523T patent/PL3122378T3/pl unknown
- 2015-03-24 KR KR1020197010177A patent/KR102027429B1/ko active IP Right Grant
- 2015-03-24 LT LTEP15711523.9T patent/LT3122378T/lt unknown
- 2015-03-24 JP JP2016558699A patent/JP6894237B2/ja active Active
- 2015-03-24 BE BE20155175A patent/BE1022857A1/fr not_active IP Right Cessation
- 2015-03-24 EP EP19211691.1A patent/EP3639850A1/en not_active Withdrawn
- 2015-03-24 RS RS20200215A patent/RS59971B1/sr unknown
- 2015-03-24 KR KR1020167028541A patent/KR20160132109A/ko active Application Filing
- 2015-03-24 MX MX2016012538A patent/MX2016012538A/es active IP Right Grant
- 2015-03-24 SG SG11201606887WA patent/SG11201606887WA/en unknown
- 2015-03-24 BE BE2015/5176A patent/BE1022744B1/fr not_active IP Right Cessation
-
2016
- 2016-08-17 IL IL247328A patent/IL247328B/en active IP Right Grant
- 2016-08-22 ZA ZA2016/05818A patent/ZA201605818B/en unknown
-
2020
- 2020-01-30 CY CY20201100078T patent/CY1122537T1/el unknown
- 2020-02-11 HR HRP20200217TT patent/HRP20200217T1/hr unknown
- 2020-10-15 JP JP2020173955A patent/JP2021035950A/ja active Pending
-
2021
- 2021-04-06 IL IL282104A patent/IL282104A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301117I1 (nl) | trastuzumab deruxtecan | |
DK3110442T3 (da) | Modificerede meningokok-fhbp-polypeptider | |
IL282104A (en) | mutated staphylococcal antigens | |
ZA201604640B (en) | Novel anti-netrin-1 antibody | |
DE112015000747A5 (de) | Normal-eingerückte Kupplungsvorrichtung | |
DE112015003404A5 (de) | Dämpfersystem | |
SI3628731T1 (sl) | Novo protitelo proti presepsinu | |
DE112015001610A5 (de) | Dämpfersystem | |
GB201415602D0 (en) | Streptococcal antigens | |
DK3154141T3 (da) | Koblingsanordning | |
DE112015004799A5 (de) | Schwungrad | |
DK3193923T3 (da) | Adjuvanser | |
ES1123006Y (es) | Almohada | |
ES1133985Y (es) | Almohada | |
UA30501S (uk) | Подушка | |
UA30502S (uk) | Подушка | |
UA28626S (uk) | Набір зчеплення | |
TH1401007066B (th) | อุปกรณ์บังคับทิศทาง | |
TH1401004289B (th) | อุปกรณ์คลัตช์ | |
UA30076S (uk) | Пас поліклиновий | |
FI10456U1 (fi) | Tulisija | |
TH1501000215B (th) | อุปกรณ์คลัตช์ |